Literature DB >> 29800297

Fine-tuning the structure of glycosaminoglycans in living cells using xylosides.

Andrea Persson1, Ulf Ellervik2, Katrin Mani1.   

Abstract

Xylosides can induce the formation and secretion of xyloside-primed glycosaminoglycans when administered to living cells; however, their impact on the detailed glycosaminoglycan structure remains unknown. Here, we have systematically investigated how the xyloside concentration and the type of xyloside, as well as the cell type, influenced the structure of xyloside-primed glycosaminoglycans in terms of the heparan sulfate and chondroitin/dermatan sulfate proportion and disaccharide composition. We found that although greatest influence was exerted by the cell type, both the xyloside concentration and type of xyloside impacted the proportion of heparan sulfate and the complexity of chondroitin/dermatan sulfate. The disaccharide composition of the chondroitin/dermatan sulfate was influenced by the xyloside concentration and type of xyloside to a higher extent than that of the heparan sulfate; the proportion of 4S-sulfated disaccharides in the chondroitin/dermatan sulfate decreased and the proportions of 6S-sulfated and/or nonsulfated disaccharides increased both with increasing concentrations of xyloside and with increasing xyloside hydrophobicity, whereas the proportion of nonsulfated disaccharides was primarily altered in the heparan sulfate with increasing concentrations of xyloside. Our results indicate that it is feasible to not only produce large amounts of glycosaminoglycans in living cells but also to fine-tune their structures by using xylosides of different types and at different concentrations.

Entities:  

Mesh:

Substances:

Year:  2018        PMID: 29800297     DOI: 10.1093/glycob/cwy049

Source DB:  PubMed          Journal:  Glycobiology        ISSN: 0959-6658            Impact factor:   4.313


  5 in total

Review 1.  Heparin Binding Proteins as Therapeutic Target: An Historical Account and Current Trends.

Authors:  Giancarlo Ghiselli
Journal:  Medicines (Basel)       Date:  2019-07-29

2.  Azide-Functionalized Naphthoxyloside as a Tool for Glycosaminoglycan Investigations.

Authors:  Daniel Willén; Roberto Mastio; Zackarias Söderlund; Sophie Manner; Gunilla Westergren-Thorsson; Emil Tykesson; Ulf Ellervik
Journal:  Bioconjug Chem       Date:  2021-11-16       Impact factor: 4.774

3.  Fluorescently labeled xylosides offer insight into the biosynthetic pathways of glycosaminoglycans.

Authors:  Roberto Mastio; Daniel Willén; Zackarias Söderlund; Gunilla Westergren-Thorsson; Sophie Manner; Emil Tykesson; Ulf Ellervik
Journal:  RSC Adv       Date:  2021-11-29       Impact factor: 3.361

4.  A novel cytoskeletal action of xylosides.

Authors:  Caitlin P Mencio; Sharada M Tilve; Masato Suzuki; Kohei Higashi; Yasuhiro Katagiri; Herbert M Geller
Journal:  PLoS One       Date:  2022-06-28       Impact factor: 3.752

5.  Odiparcil, a potential glycosaminoglycans clearance therapy in mucopolysaccharidosis VI-Evidence from in vitro and in vivo models.

Authors:  Eugeni Entchev; Ingrid Jantzen; Philippe Masson; Stephanie Bocart; Bruno Bournique; Jean-Michel Luccarini; Andre Bouchot; Olivier Lacombe; Jean-Louis Junien; Pierre Broqua; Mireille Tallandier
Journal:  PLoS One       Date:  2020-05-15       Impact factor: 3.240

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.